1. Home
  2. AZN

AZN

AstraZeneca PLC

Logo AstraZeneca PLC

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.

Founded: 1992 Country:
United Kingdom
United Kingdom
Employees: N/A City: N/A
Market Cap: 209.1B IPO Year: 1993
Target Price: $81.67 AVG Volume (30 days): 6.3M
Analyst Decision: Buy Number of Analysts: 6
Dividend Yield: 2.12% Dividend Payout Frequency: Semi-Annual
EPS: 1.91 EPS Growth: 80.57
52 Week Low/High: $60.47 - $76.56 Next Earning Date: 04-25-2024
Revenue: $45,811,000,000 Revenue Growth: 3.29%
Revenue Growth (this year): 13.77% Revenue Growth (next year): 7.32%

Share on Social Networks: